Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
about
Cerebral small vessel disease and Alzheimer's diseaseClinical-pathological agreement in dementing disorders: embracing the complexityReconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease?Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelatedPost-mortem brain analyses of the Lothian Birth Cohort 1936: extending lifetime cognitive and brain phenotyping to the level of the synapseCerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly.The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment.Cerebral white matter lesions - associations with Aβ isoforms and amyloid PETSleep Disordered Breathing and White Matter Hyperintensities in Community-Dwelling Elders.Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant.Accelerated decline in white matter integrity in clinically normal individuals at risk for Alzheimer's diseaseElevated cerebrovascular resistance index is associated with cognitive dysfunction in the very-old.Regional white matter hyperintensity volume and cognition predict death in a multiethnic community cohort of older adults.Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors.White matter and cognition: making the connection.White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults.Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.Different clinical effect of four antidementia drugs for Alzheimer's disease patients depending on white matter severity.Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease.Blood will out: vascular contributions to Alzheimer's disease.White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes.A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease.Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics.Molecular Mechanisms of Oligodendrocyte Regeneration in White Matter-Related Diseases.An MRI measure of degenerative and cerebrovascular pathology in Alzheimer diseaseMultimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progressionAgeing, Cellular Senescence and Neurodegenerative Disease
P2860
Q26775897-A8500DFB-023D-44DB-9C0B-D5B171D80826Q34577618-AEF892A7-E951-479D-8724-8FD6082E1B56Q34714991-B92B2A93-C684-4134-A42C-0830C0E54CB7Q35276630-607A442E-9CA4-4EA1-AEBB-18840C4C367BQ35604010-534D0297-FC81-4BFC-9082-9AF02F38C448Q36025046-CA0D0B8C-62F1-489F-BD83-F2DECA1921D1Q36332727-B526806C-D413-4E75-A762-D0B70FA09A87Q36366566-544EECE4-83E4-4E1B-B1C5-F9FC773F6D60Q36559869-69FE3F1F-7F41-45CA-8ECB-4D75D50A3266Q36686478-F519FA94-3622-4031-BC09-34EFEDF4562BQ36765873-6012A377-DBA5-4191-ADEF-230D238630F6Q36870947-2C18830B-8432-4000-924A-AD954D45BDE6Q37090009-8019511D-3F51-4F46-9B15-8C905D05B177Q37418306-B4C9AA0A-74E0-4193-9564-E0FCDA88C419Q37562875-ADC0FF92-A5C7-49BB-ABEE-511DAB225F0FQ38924413-C1A0AFBA-6F01-4A53-AE9F-360F8A4E942BQ39888008-51F1591C-95C2-4CBF-8388-C4F523726134Q46187973-88B6D64D-9D8C-4F68-9499-233730761690Q47194404-55D63149-5552-490E-B4D5-D2767FA408CAQ47781003-03D6D7D8-FC81-403A-98E7-FF6F00555159Q47928299-7652F2AF-8B8D-4ECF-BC32-1C1A509768CFQ49498166-1AAEC6F5-E357-4781-A87B-30819F45797DQ51766085-6611274D-5F83-45B7-A6E9-D24AD2FAFF52Q55234157-EA4C5B6A-A9AA-473B-B814-875373F8B198Q55257582-2D106705-BD96-4E9E-A60E-EFD97B750CECQ55617506-0C5C3642-5D88-4A09-B893-F33252B3A3ADQ57291686-268D85F9-3B0C-48E5-AB63-2FD5926DE9DFQ58701999-C29CB1E7-F75A-42F1-BFA5-BC5545F46A58Q59133878-5218CC81-F1A5-4687-8B4F-7B324F1C6D42
P2860
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
@ast
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
@en
type
label
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
@ast
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
@en
prefLabel
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
@ast
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
@en
P2860
P1476
Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.
@en
P2093
Adam M Brickman
P2860
P2888
P356
10.1007/S11910-013-0415-7
P577
2013-12-01T00:00:00Z